Robin J Kastenmayer

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint A retrospective study of idiopathic ulcerative dermatitis in mice with a C57BL/6 background
    Robin J Kastenmayer
    National Institute of Health, National Institute of Allergy and Infectious Diseases, Rocville, Maryland, USA
    J Am Assoc Lab Anim Sci 45:8-12. 2006
  2. pmc Select agent and toxin regulations: beyond the eighth edition of the Guide for the Care and Use of Laboratory Animals
    Robin J Kastenmayer
    Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA
    J Am Assoc Lab Anim Sci 51:333-8. 2012
  3. ncbi request reprint Variation in organ volumes of matched BALB/c mice by microcomputed tomography analysis
    Robin J Kastenmayer
    National Institutes of Health, National Institute of Allergy and Infectious Diseases, Comparative Medicine Branch, Rockville, MD, USA
    J Am Assoc Lab Anim Sci 46:7-12. 2007
  4. pmc Eradication of murine norovirus from a mouse barrier facility
    Robin J Kastenmayer
    National Institute of Allergy and Infectious Diseases, Comparative Medicine Branch, National Institutes of Health, Bethesda, MD, USA
    J Am Assoc Lab Anim Sci 47:26-30. 2008
  5. pmc Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus)
    Laura E Via
    Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute for Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA
    Infect Immun 81:2909-19. 2013
  6. pmc Attenuation and immunogenicity of host-range extended modified vaccinia virus Ankara recombinants
    Sharon Melamed
    Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, United States
    Vaccine 31:4569-77. 2013
  7. pmc Murine norovirus infection has no significant effect on adaptive immunity to vaccinia virus or influenza A virus
    Scott E Hensley
    Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 208921, USA
    J Virol 83:7357-60. 2009
  8. pmc Elimination of A-type inclusion formation enhances cowpox virus replication in mice: implications for orthopoxvirus evolution
    Robin J Kastenmayer
    Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 33 North Drive, MSC 3210, Bethesda, MD 20892 3210, USA
    Virology 452:59-66. 2014
  9. pmc Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography
    Laura E Via
    Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute for Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA
    Antimicrob Agents Chemother 56:4391-402. 2012
  10. pmc Management and care of African dormice (Graphiurus kelleni)
    Robin J Kastenmayer
    National Institutes of Health, National Institute of Allergy and Infectious Diseases, Comparative Medicine Branch, Bethesda, Maryland
    J Am Assoc Lab Anim Sci 49:173-6. 2010

Collaborators

Detail Information

Publications10

  1. ncbi request reprint A retrospective study of idiopathic ulcerative dermatitis in mice with a C57BL/6 background
    Robin J Kastenmayer
    National Institute of Health, National Institute of Allergy and Infectious Diseases, Rocville, Maryland, USA
    J Am Assoc Lab Anim Sci 45:8-12. 2006
    ....
  2. pmc Select agent and toxin regulations: beyond the eighth edition of the Guide for the Care and Use of Laboratory Animals
    Robin J Kastenmayer
    Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA
    J Am Assoc Lab Anim Sci 51:333-8. 2012
    ..Here we provide some background information regarding the relevant laws and regulations, as well as an overview of the programmatic requirements pertaining to the use of Select Agents, with a focus on use in animals...
  3. ncbi request reprint Variation in organ volumes of matched BALB/c mice by microcomputed tomography analysis
    Robin J Kastenmayer
    National Institutes of Health, National Institute of Allergy and Infectious Diseases, Comparative Medicine Branch, Rockville, MD, USA
    J Am Assoc Lab Anim Sci 46:7-12. 2007
    ..These data suggest that to obtain the widest range of possible values, among which the true value would be found, multiple analyses of multiple scans of the same mouse must be performed by multiple scan evaluators...
  4. pmc Eradication of murine norovirus from a mouse barrier facility
    Robin J Kastenmayer
    National Institute of Allergy and Infectious Diseases, Comparative Medicine Branch, National Institutes of Health, Bethesda, MD, USA
    J Am Assoc Lab Anim Sci 47:26-30. 2008
    ....
  5. pmc Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus)
    Laura E Via
    Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute for Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA
    Infect Immun 81:2909-19. 2013
    ..tuberculosis strain clades. ..
  6. pmc Attenuation and immunogenicity of host-range extended modified vaccinia virus Ankara recombinants
    Sharon Melamed
    Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, United States
    Vaccine 31:4569-77. 2013
    ..The extended host range of rMVAs may be useful for vaccine production. ..
  7. pmc Murine norovirus infection has no significant effect on adaptive immunity to vaccinia virus or influenza A virus
    Scott E Hensley
    Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 208921, USA
    J Virol 83:7357-60. 2009
    ....
  8. pmc Elimination of A-type inclusion formation enhances cowpox virus replication in mice: implications for orthopoxvirus evolution
    Robin J Kastenmayer
    Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 33 North Drive, MSC 3210, Bethesda, MD 20892 3210, USA
    Virology 452:59-66. 2014
    ..Deletion of the gene for embedding virions had a lesser effect, possibly due to known additional functions of the encoded protein. ..
  9. pmc Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography
    Laura E Via
    Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute for Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA
    Antimicrob Agents Chemother 56:4391-402. 2012
    ..The results from this study suggest that rabbits may be a useful surrogate species for evaluating novel chemotherapies and understanding changes in both PET and CT scans in human clinical trials...
  10. pmc Management and care of African dormice (Graphiurus kelleni)
    Robin J Kastenmayer
    National Institutes of Health, National Institute of Allergy and Infectious Diseases, Comparative Medicine Branch, Bethesda, Maryland
    J Am Assoc Lab Anim Sci 49:173-6. 2010
    ..The development of a program for the husbandry and care of African dormice at our institution typifies the experiences of many laboratory animal facilities that are asked to support the development of animal models using novel species...